Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
13.15
0.25 (1.94%)
At close: Aug 15, 2025, 3:59 PM
12.97
-1.37%
After-hours: Aug 15, 2025, 07:43 PM EDT

Ginkgo Bioworks Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-315.19M -472.07M -547.03M -651.19M -897.68M -853.81M -892.87M -855.33M -1.22B -1.72B -2.11B -3.54B -2.97B -2.35B -1.84B -278.05M -201.7M -175.89M
Depreciation & Amortization
63.98M 65.52M 63.02M 60.2M 63.53M 64.42M 70.51M 73.49M 62.51M 53.89M 44.42M 36.6M 35.38M 32.94M 29.08M 25.08M 20.32M 16.34M
Stock-Based Compensation
77.09M 91.99M 112.34M 134.62M 173.34M 197.68M 229.88M 295.22M 805.78M 1.35B 1.93B 3.41B 2.85B 2.26B 1.61B 14.88M 14.87M 471K
Other Working Capital
-23.04M -7.37M 2.13M 46.72M 6.17M -15.87M -21.6M -72.29M -82.25M -94.73M -81.35M -47.73M 5.66M 46.52M 55.43M 54.73M 16.59M 8.34M
Other Non-Cash Items
-25.3M 42.42M 49.9M 70.85M 154.05M 113.5M 111.76M 42.92M 54.91M 31.14M -69.28M -57.68M -87.91M -102.24M -20.95M -12.13M -2.57M -369K
Deferred Income Tax
n/a n/a n/a -801K 146.03M 146.1M 146.1M 132.29M -14.54M -14.61M -14.61M -57.88M 12.62M 14.21M 30.21M 85.09M 14.6M 13.01M
Change in Working Capital
-38.29M -9.7M 2.18M 51.33M 55.7M 37.94M 39.11M -30.97M 15.72M -25.37M -37.01M -110.6M -130.22M -74.76M -61.54M 17.51M -13.18M -13.5M
Operating Cash Flow
-237.71M -281.85M -319.58M -334.98M -305.03M -294.17M -295.5M -342.37M -297.12M -322.88M -252.2M -313.04M -289.97M -225.59M -253.82M -147.62M -167.65M -159.95M
Capital Expenditures
-36.46M -63.45M -62.54M -52.28M -41.57M -28.07M -40.8M -63M -72.09M -68.13M -52.27M -31.74M -23.7M -38.17M -56.52M -70.82M -94.05M -76.48M
Cash Acquisitions
-134K -134K -5.53M -47.14M -46.88M -44.57M -38.55M 86.02M 56.9M 56.03M 26.65M -47.04M -38.16M -39.6M -12.04M -21.38M -1.21M -1.21M
Purchase of Investments
-320.13M -191.18M n/a n/a n/a n/a n/a 10M n/a -6.5M -10.19M -25.19M -20.19M -13.69M -1.74B -1.73B -1.73B -1.73B
Sales Maturities Of Investments
69.48M 4.52M 4.52M 3.95M n/a n/a n/a n/a n/a 6.5M 6.5M 11.2M 11.07M 4.7M 4.7M n/a 124.3K n/a
Other Investing Acitivies
1.39M 1.44M 1.32M -356K -559K 1.56M 969K -34.99M -29.89M -38.73M -38.08M -135K -6.07M 567K 608K -9.11M -9.11M -9.2M
Investing Cash Flow
-285.86M -248.81M -62.24M -95.83M -89.01M -73.39M -80.69M -4.28M -47.38M -50.82M -67.39M -92.91M -76.93M -86.2M -73.26M -106.31M -104.37M -86.89M
Debt Repayment
-708K -810K -897K -1.01M -1.14M -1.27M -1.29M -1.13M -1.11M -1.21M -1.18M -1.38M -1.4M -1.12M -1.12M -957K -801K -828K
Common Stock Repurchased
n/a n/a n/a n/a n/a -12K -12K -12K -12K -75K -1.06M -10.52M -35.52M -35.44M -34.46M -25M n/a n/a
Dividend Paid
n/a n/a n/a -554K -554K -554K -554K n/a n/a n/a n/a -24.96M -24.96M -24.96M -24.96M n/a n/a n/a
Other Financial Acitivies
-261K -301K -922K -199K 80K -935K -880K -2.82M -2.92M -2.2M -2.54M -2.55M 1.55B 1.54B 1.54B 1.55B 20.33M 94.3M
Financial Cash Flow
-973K -1.1M -1.74M -2.17M -2.02M -3.17M -3.22M 95.35M 95.21M 95.64M 95.34M -13.64M 1.53B 1.53B 1.53B 1.55B 19.52M 93.47M
Net Cash Flow
-526.18M -531.81M -383.84M -433.08M -396.32M -371.45M -380M -250.89M -248.77M -277.18M -223.35M -419.79M 1.17B 1.22B 1.21B 1.29B -252.49M -153.37M
Free Cash Flow
-274.17M -345.3M -382.13M -377.98M -337.32M -312.97M -327.02M -405.37M -369.21M -391.02M -304.47M -344.78M -313.68M -263.75M -310.34M -218.44M -261.7M -236.43M